R&D, Pharmacovigilance & Regulatory Affairs_uk

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

Title Location Date Sort ascending Req ID
Reset
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 10 Feb 2026 6592
Senior Director, Clinical Biometrics & Analytics Parma, IT 12 Feb 2026 6387
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 16 Feb 2026 6111
R&D Manufacturing & Technology Transfer Manager Parma, IT 18 Feb 2026 6501
Clinical Program Leader, Neonatology & Care
Clinical Program Leader, Neonatology & Care Europe, IT 19 Feb 2026 6955
Europe, IT 19 Feb 2026 6955
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US 20 Feb 2026 6204
United States, US 20 Feb 2026 6204
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 27 Feb 2026 5993
PARMA, IT 27 Feb 2026 5993